Skip to content

Change in AR at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$6.5M+110%
Harmony Biosciences Holdings, Inc. logo
Harmony Biosciences Holdings, Inc.HRMY
$11.44M-50.1%
Nuvation Bio logo
Nuvation BioNUVB
$6.65M+154%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-$3.42M-106%
Septerna, Inc. logo
Septerna, Inc.SEPN
$486K+515%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$0+100%

Other financials

Income statement

See full
Revenue$6.2M-96.1%
Operating income-$53.4M-148%
Net income-$50.0M-144%
EPS (diluted)-$0.79-142%

Balance sheet

See full
Cash & equivalents$155.7M-43.4%
Total debt$3.4M-42.5%
Total equity$394.9M+12.8%
Total assets$443.3M+8.9%

Cash flow

See full
Operating cash flow-$60.6M-146%
CapEx$353.0K+132%
Free cash flow-$60.9M-146%

Valuation

See full
Market cap$1.94B+436%
Enterprise value$1.79B+1,855%
P/S60.4×+58.5×

Profitability

See full
Operating margin-577.5%-597pp
Net margin-529.2%-556pp
FCF margin36.2%+18.4pp

Returns & leverage

See full
Return on equity-45.6%-66.1pp
Debt / equity0.0×
Current ratio+0.6×

Where this comes from

Reported directly by Stoke Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stoke Therapeutics, Inc.'s change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stoke Therapeutics, Inc.'s change in AR?
Stoke Therapeutics, Inc. (STOK) reported change in AR of -$1.49M in Q1 2026.
How has Stoke Therapeutics, Inc.'s change in AR changed year-over-year?
Stoke Therapeutics, Inc.'s change in AR decreased by 212.2% year-over-year, from $1.33M to -$1.49M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.